Promising monotherapy activity observed in all three major metastatic colorectal cancer subtypes harboring high tumor mutational burden (MSS RASwt, MSS RASmut and PD-1 resistant MSI-H)...
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and...
The anti-CCR8 antibodies market holds potential in addressing unmet needs across inflammatory and cancerous diseases. The anti-CCR8 inhibitor market is expected to witness substantial...
The anti-CCR8 antibodies market holds potential in addressing unmet needs across inflammatory and cancerous diseases. The anti-CCR8 inhibitor market is expected to witness substantial...
"Harnessing the Power of the Immune System: How Cancer Immunotherapy and Oncolytic Virology Are Reshaping the Future of Oncology in a Digitally Driven Era"
BOSTON,...
LONDON, June 26, 2025 /PRNewswire/ -- New data from NatWest Rooster Money shows the Tooth Fairy is beating inflation with the cost of visits increasing...
Every year in B.C., approximately 130 children are diagnosed with cancer. As the province's only full-service acute-care hospital dedicated to children, BC Children's Hospital...
As the CU Cancer Center celebrates its 40th anniversary, here are five ways it helped to change detection and treatment of the disease.
AURORA, Colo.,...
Survey of over 6,000 people finds the UK is more trusting, friendly and community-minded than some may thinkThree quarters of people trust their neighbours (73%)...
In a landmark advancement for women's cancer research, Dr. Takuma Hayashi and his team have made groundbreaking discoveries that could transform our understanding and...
New Team Science Award is $1.5 million Over Three Years
NEW YORK, June 17, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announces today...
$2.25 Million Research Collaboration Focused on Understanding and Treating Lung Cancers Harboring HER2 Mutations; call for Requests for Proposals
NEW YORK, June 17, 2025 /PRNewswire/...